Verve Therapeutics Overview

Verve Therapeutics Other Income Expense Net

Other Income/Expense Net for VERV.

Quarterly Other Income/Expense

$5.68M

↓ 30.83% YoY

As of Mar 31, 2025

Annual Other Income/Expense (TTM)

$27.77M

↑ 40.08% YoY

Trailing 12 months ending Mar 31, 2025

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin